PRAC meeting highlights 28 September - 1 October 2026
02/10/2026
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
Highlights from the October 2026 meeting are now available on the EMA website